Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.29.1 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.29.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.29.2 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.29.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BC.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.5.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAZEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XAZEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.2.85EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.85EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.65EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.65EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BG.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DJ.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DJ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.21EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.11.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.6.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used